Blood Glucose
"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
| Descriptor ID |
D001786
|
| MeSH Number(s) |
D09.947.875.359.448.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 11 | 12 | | 1997 | 1 | 5 | 6 | | 1998 | 0 | 7 | 7 | | 1999 | 1 | 12 | 13 | | 2000 | 2 | 10 | 12 | | 2001 | 1 | 6 | 7 | | 2002 | 4 | 7 | 11 | | 2003 | 5 | 16 | 21 | | 2004 | 13 | 12 | 25 | | 2005 | 5 | 17 | 22 | | 2006 | 6 | 18 | 24 | | 2007 | 12 | 20 | 32 | | 2008 | 12 | 23 | 35 | | 2009 | 10 | 48 | 58 | | 2010 | 14 | 26 | 40 | | 2011 | 14 | 26 | 40 | | 2012 | 16 | 27 | 43 | | 2013 | 20 | 29 | 49 | | 2014 | 29 | 42 | 71 | | 2015 | 19 | 38 | 57 | | 2016 | 27 | 43 | 70 | | 2017 | 23 | 44 | 67 | | 2018 | 36 | 45 | 81 | | 2019 | 48 | 44 | 92 | | 2020 | 24 | 60 | 84 | | 2021 | 11 | 67 | 78 | | 2022 | 11 | 73 | 84 | | 2023 | 13 | 56 | 69 | | 2024 | 35 | 55 | 90 | | 2025 | 30 | 58 | 88 | | 2026 | 18 | 34 | 52 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Oser TK, Martens T, Ruedy KJ, Bergford S, Calhoun P, Chang KL, Kramer ES, Klug BA, Anderson RL, Cook BR, Pickering D, Ortega M, Peterson B, Davidson L, Schmid R, Desai ND, Burkett E, Haynes JL, Herman A, Topiwala SM, Bailey R, Oser SM, Cadet NN, Johnson ML, Elkind-Hirsch KE, Beck SE, Castle JR, Beck RW. Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes. N Engl J Med. 2026 Oct 29; 395(17):1717-1727.
-
Hoffman EA, Phoebe AM, Trujillo MN, Zhang WC, Jennings EQ, Farrera DO, Orlicky DJ, Rutt LN, McCullough RL, Huacachino AA, Marcinkiewicz MM, Snyder NW, Bruner KR, Payan KB, Martinez DJF, Stern JH, Galligan JJ. Glyoxalase 1 loss reduces fatty liver but impairs glucose handling in male mice. Physiol Rep. 2026 Sep; 14(17):e71106.
-
Montaser E, Bhasin K, Kruger D, Akturk HK, Ahmann A, Snell-Bergeon JK, Shah VN. Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study. Diabetes Obes Metab. 2026 Nov; 28(11):10736-10742.
-
Valdez Y, Segev N, Parimi N, Vegesna M, Brown EA, Samuels S, Van Name M, Shah AS, Wolf RM. Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis. J Pediatr Endocrinol Metab. 2026 Oct 26; 39(10):1007-1016.
-
Wang Y, Sargent JL, Mathieu C, Vazquez-Arreola E, Perreault L, Loos RJF, Lim LL, Sandforth L, Hanson RL, Kullmann S, Sbierski-Kind J, Brucker SY, Hrabé de Angelis M, Theiss F, Icks A, Mohebbi D, Stefan N, Mohan V, Wang T, Preissl H, Bergman M, Tuomilehto J, Hivert MF, Franks PW, Birkenfeld AL. Type 2 diabetes prevention across the life course. Nat Med. 2026 Aug; 32(8):2757-2773.
-
Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, Blangero J, Bowden DW, Carson AP, Chen YI, Chung MK, Curran JE, Darbar D, Duggirala R, Ellinor PT, Fatkin D, Fornage M, Heard-Costa N, He J, Hou L, Kardia SLR, Kooperberg C, Loos RJF, McManus DD, Mitchell BD, Minster RL, North KE, Psaty BM, Raffield LM, Redline S, Rich SS, Roden D, Rotter JI, Shoemaker MB, Smith JD, Van Wagoner DR, Aguet F, Ardlie K, Bis JC, Brody JA, Cade BE, Clish CB, de Vries PS, Floyd JS, Freedman BI, Gabriel S, Gerzsten RE, Goodarzi MO, Gu C, Guo X, Gupta N, Heckbert SR, Hsu S, Hung YJ, Kalyani RR, Kelly TN, Kinney GL, Li C, Liu S, Liu Y, Lloyd-Jones DM, Manson JE, Mathias RA, Mercader JM, Morrison AC, Naseri T, Onengut S, Palmer ND, Peyser PA, Qi Q, Raghavan S, Reiner AP, Rooney MR, Sevilla-Gonzalez M, Sarnowski C, Smith JD, Smith JA, Spartano NL, Tahir U, Taylor KD, Tobias DK, Tracy RP, Viali S, Wang H, Wood AC, Yanek LR, Zhao W, Zheng Y, Dupuis J, Liu CT, Sladek R, Wessel J, Meigs JB, Manning AK. Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program. Diabetes. 2026 Aug 01; 75(8):1477-1491.
-
Xi Y, Thorand B, Schneider A, Wolf K, Dallavalle M, Nikolaou N, Linkohr B, Kronenberg F, Rathmann W, Schlesinger S, Herder C, Schwettmann L, Zeller T, Jumpertz von Schwartzenberg R, Breitner-Busch S, Peters A. Association of long-term exposure to air pollution, built environment and air temperature with the incidence of prediabetes phenotypes, and prediabetes remission and progression to type 2 diabetes: a longitudinal study in the KORA cohort. Diabetologia. 2026 Oct; 69(10):2819-2832.
-
Davis GM, Forlenza GP, Gehr B, Pemberton J, Penfornis A, Do D, Huyett LM, Ly TT. Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes. Diabetes Res Clin Pract. 2026 Sep; 239:113450.
-
Martens TW, Patel BV, Wang SM, Messer LH, Pinsker JE, Malone DC, Polin MR, Brixner DI, Isaacs D, Ebekozien O. Impact of Automated Insulin Delivery on Type 2 Diabetes Measures. Am J Manag Care. 2026 Jul 01; 32(7):e222-e227.
-
Cook TM, Bethea M, da Silva Teixeira S, Birznieks C, McClennan A, Hendrix J, Benninger RK, Patti ME, Sandoval DA. Dysregulated glucagon signaling contributes to hypoglycemia after vertical sleeve gastrectomy in mice. Mol Metab. 2026 08; 110:102399.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|